Healthcare provider profile · identity verified

Eric Beaver, M.D.

Family Practice · OKLAHOMA CITY, OK · NPI 1669866737

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	179	63
Amlodipine Besylate	Amlodipine Besylate	118	42
Gabapentin	Gabapentin	109	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	26
Pantoprazole Sodium	Pantoprazole Sodium	97	27
Lisinopril	Lisinopril	94	40
Losartan Potassium	Losartan Potassium	90	32
Metformin Hcl	Metformin Hcl	85	26
Levothyroxine Sodium	Levothyroxine Sodium	68	23
Trazodone Hcl	Trazodone Hcl	68	20
Albuterol Sulfate Hfa	Albuterol Sulfate	64	28
Eliquis	Apixaban	61	20
Furosemide	Furosemide	61	25
Duloxetine Hcl	Duloxetine Hcl	59	15
Potassium Chloride	Potassium Chloride	57	20
Metoprolol Tartrate	Metoprolol Tartrate	55	19
Metoprolol Succinate	Metoprolol Succinate	52	22
Tamsulosin Hcl	Tamsulosin Hcl	46	17
Escitalopram Oxalate	Escitalopram Oxalate	45	14
Pregabalin	Pregabalin	45	suppressed
Carvedilol	Carvedilol	43	18
Rosuvastatin Calcium	Rosuvastatin Calcium	43	13
Montelukast Sodium	Montelukast Sodium	40	15
Jardiance	Empagliflozin	36	12
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Omeprazole	Omeprazole	35	15
Ozempic	Semaglutide	35	17
Simvastatin	Simvastatin	34	15
Bupropion Xl	Bupropion Hcl	33	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	32	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Tramadol Hcl	Tramadol Hcl	31	11
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	11
Meloxicam	Meloxicam	28	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	28	suppressed
Alprazolam	Alprazolam	26	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Famotidine	Famotidine	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Celecoxib	Celecoxib	22	suppressed
Glipizide	Glipizide	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Sertraline Hcl	Sertraline Hcl	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Allopurinol	Allopurinol	17	suppressed
Dapagliflozin	Dapagliflozin Propanediol	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Prednisone	Prednisone	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Torsemide	Torsemide	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Diclofenac Potassium	Diclofenac Potassium	13	suppressed
Finasteride	Finasteride	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Dofetilide	Dofetilide	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error